Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · IEX Real-Time Price · USD
0.373
+0.018 (4.95%)
At close:
Oct 4, 2022 4:00 PM
0.402
+0.029 (7.77%)
After-hours:
Oct 4, 2022 4:55 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Selling, General & Admin
|
9.34 | 5.07 | 4.28 | 6.62 | 0.81 | 0.26 |
| Research & Development
|
8.4 | 5.85 | 3.97 | 0.37 | 0.18 | 0.15 |
| Other Operating Expenses
|
1.55 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
|
19.29 | 10.93 | 8.24 | 6.99 | 1 | 0.41 |
| Operating Income
|
-19.29 | -10.93 | -8.24 | -6.99 | -1 | -0.41 |
| Interest Expense / Income
|
0 | 0 | 0 | 1.17 | 0.14 | 0.01 |
| Other Expense / Income
|
0.23 | -0.03 | 0.35 | 3.48 | -0 | -0 |
| Pretax Income
|
-19.52 | -10.89 | -8.59 | -11.63 | -1.14 | -0.42 |
| Income Tax
|
-0.09 | 0 | 0 | 0 | 0 | 0 |
| Net Income
|
-19.42 | -10.89 | -8.59 | -11.63 | -1.14 | -0.42 |
| Net Income Common
|
-19.42 | -10.89 | -8.59 | -11.63 | -1.14 | -0.42 |
| Shares Outstanding (Basic)
|
19 | 12 | 10 | 5 | 3 | 3 |
| Shares Outstanding (Diluted)
|
19 | 12 | 10 | 5 | 3 | 3 |
| Shares Change
|
49.15% | 26.50% | 107.01% | 45.80% | 0.20% | - |
| EPS (Basic)
|
-1.04 | -0.87 | -0.87 | -2.44 | -0.35 | -0.13 |
| EPS (Diluted)
|
-1.04 | -0.87 | -0.87 | -2.44 | -0.35 | -0.13 |
| Free Cash Flow Per Share
|
-0.65 | -0.61 | -0.64 | -0.53 | -0.15 | -0.08 |
| Effective Tax Rate
|
0.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA
|
-19.46 | -10.89 | -8.59 | -10.46 | -0.99 | -0.41 |
| Depreciation & Amortization
|
0.06 | 0 | 0 | 0 | 0 | 0 |
| EBIT
|
-19.52 | -10.89 | -8.59 | -10.46 | -0.99 | -0.41 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).